CynapseDx Company

Analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease
Industry: Longevity Biomarkers
Headquarters: Liverpool, Liverpool, United Kingdom
Founded Date: 2010
Employees Number: 1-10
Funding Status: Seed
Investors Number: 1
Last Funding Date: 08-05-2015
Last Funding Type: Seed

Visit Website
info@cynapsedx.com
Register and Claim Ownership